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Conclusion: This study demonstrates clinical aromather-
apy is clinically safe but not statistically signiﬁcant in
effectiveness when measuring improvements in the BPSD
and ADL of dementia patients. To develop high quality care
with clinical aromatherapy for the elderly with dementia in
Japan’s ageing society further research into therapeutic effects
is required to fully establish evidence for practicing effectively
and safely in medical institutions.
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Purpose: To learn patient and health care provider expe-
riences testing for, discussing and treating mutations in the
methylenetetrahydrofolate reductase (MTHFR) enzyme.
Methods: A qualitative study was designed to investigate
doctors’ and patients’ experiences with the diagnosis MTHFR
polymorphisms, treatment with methylfolate, and therapeu-
tic responses. A structured interview guide was prepared
focused on domains of: diagnostic indications, response to
results, therapeutic approaches, treatment responses, and
safety. Following IRB approval, focus groups were conducted
with patients and doctors with relevant experience. Audio
recordings were transcribed and uploaded into Dedoose soft-
ware to aid coding and theme aggregation. Using an inductive/
deductive analytic construct, data were ﬁrst analyzed using
a priori coding. Data were then aggregated into themes and
domains. Pertinent, illustrative quoteswere selected to convey
authentic experiences.
Results: Thirty patients and eight doctors participated in
the focus groups. Patient themes included the emotional
experience of receiving diagnosis, classiﬁcation of signs and
symptoms, and challenges with treatment protocols. They
expressed confusion over their diagnosis, and frustration with
the state of knowledge their providers had regarding MTHFR.
The most common presenting symptoms were: fatigue (21%),
hormone imbalances (13%), neurological symptoms (13%), and
brain fog (8%). Providers relied on trial and error to determine
effective doses, treatment frequency and protocols. Patients
reported improvements in physical energy (31%), other phys-
ical symptoms (27%), mood (25%), behaviors (6%) and other
mental symptoms (6%). Side effects occurred in a minority
of participants but ranged in severity and were reported in
almost every body system.
Conclusion: Testing, discussing and treating MTHFR poly-
morphisms is currently a variable clinical process. Patients
suggest treatment can improve mental, emotional, and phys-
ical well-being. Diverse side effects pose a challenge in
anticipating adverse responses for clinicians. Clinicians and
patients would beneﬁt from therapeutic algorithms that were
based on rigorous research.
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Purpose: Korean folk medicine is widely used by people
living in all areas of the country. Despite a long tradition of use,
ingestion or application of plants andother substances used in
Korean folk medicine can lead to serious adverse events. Use
of folk medicine without consulting an expert may increase
the risks of complications. We aimed to develop a reporting
form for adverse events associated with the use of Korean folk
medicine.
Methods: We developed an adverse event reporting form
for Korean folk medicine. The ﬁrst version of the form was
developed and tested for spontaneous reporting of adverse
events in the clinical setting. First and second revisions to the
reporting form were made based on data collected and input
from experts.
Results: We identiﬁed information that should be consid-
ered for inclusion in reports of adverse events associated with
the use of folk medicine. New reporting items were added,
including patient height, assessment of causality, and folk
medicine properties such as classiﬁcation, scientiﬁc name,
vernacular name, part used, harvesting time, storage condi-
tions, product licensing, and cautions or contraindications.
Conclusion: We developed a reporting form for adverse
events that incorporates important characteristics of Korean
folk medicine. Further development of the reporting form
requires feedback and consensus by healthcare experts. In the
future, we hope to create an adverse event reporting form for
traditional medicine and a reporting system for each country.
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